Axsome Therapeutics (AXSM) Gross Profit (2022 - 2026)
Axsome Therapeutics (AXSM) reported Gross Profit of $204.81 million for Q2 2026, up 49.9% from $136.59 million a year earlier and up 16.1% from the prior quarter.
Powered by 
Analysis
Axsome Therapeutics (AXSM) Gross Profit (2022 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Axsome Therapeutics' Gross Profit came in at $724.04 million, up 59.9% year-over-year; for FY2025, it came in at $591.02 million, up 67.7% from FY2024.
- Gross Profit has increased for three consecutive years, with a three-year compound annual growth rate of 136.2% (FY2022 to FY2025).
- By year, Gross Profit came in at $352.39 million in FY2024 (+44.1%), $244.54 million in FY2023 (+445.4%) and $44.84 million in FY2022.
- The Q2 2026 figure ranks as the highest quarterly Gross Profit in data going back to Q2 2022.
- Year over year, Gross Profit has now increased in each of the last nine quarters, with growth averaging 66.8% over the last eight quarters.
- The high point for year-over-year Gross Profit in five years was Q2 2023 (growth of 437.2%); the low point was Q1 2024 (a decline of 21.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $176.48 million (Q1 2026), $183.67 million (Q4 2025) and $159.08 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Axsome Therapeutics | 9.64 Bn | 8.37 Bn | 204.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 204.81 Mn |
| Mar 31, 2026 | 176.48 Mn |
| Dec 31, 2025 | 183.67 Mn |
| Sep 30, 2025 | 159.08 Mn |
| Jun 30, 2025 | 136.59 Mn |
| Mar 31, 2025 | 111.67 Mn |
| Dec 31, 2024 | 108.25 Mn |
| Sep 30, 2024 | 96.33 Mn |
| Jun 30, 2024 | 79.11 Mn |
| Mar 31, 2024 | 68.70 Mn |
| Dec 31, 2023 | 64.15 Mn |
| Sep 30, 2023 | 51.26 Mn |
| Jun 30, 2023 | 42.10 Mn |
| Mar 31, 2023 | 87.02 Mn |
| Dec 31, 2022 | 22.08 Mn |
| Sep 30, 2022 | 14.92 Mn |
| Jun 30, 2022 | 7.84 Mn |
API Access
Axsome Therapeutics Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=AXSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "AXSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=AXSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();